Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227

PURPOSE: This study investigated the treatment of primary CNS lymphoma with methotrexate, temozolomide (TMZ), and rituximab, followed by hyperfractionated whole-brain radiotherapy (hWBRT) and subsequent TMZ. The primary phase I end point was the maximum tolerated dose of TMZ. The primary phase II en...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Oncol
Glavni autori: Glass, Jon, Won, Minhee, Schultz, Christopher J., Brat, Daniel, Bartlett, Nancy L., Suh, John H., Werner-Wasik, Maria, Fisher, Barbara Jean, Liepman, Marcia K., Augspurger, Mark, Bokstein, Felix, Bovi, Joseph A., Solhjem, Matthew C., Mehta, Minesh P.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2016
Teme:
Original Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872318/
https://ncbi.nlm.nih.gov/pubmed/27022122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.64.8634
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items